Čarapić, Marija

Link to this page

Authority KeyName Variants
00654c63-6567-4c9d-9e10-2b412c3f1800
  • Čarapić, Marija (5)
  • Carapić, Marija (2)
Projects

Author's Bibliography

Electrochemical and theoretical study on interaction between erlotinib and DNA

Jovanović, Milan; Nikolić, Katarina; Čarapić, Marija; Aleksić, Mara

(Elsevier B.V., 2023)

TY  - JOUR
AU  - Jovanović, Milan
AU  - Nikolić, Katarina
AU  - Čarapić, Marija
AU  - Aleksić, Mara
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4931
AB  - A comprehensive investigation of tyrosine kinase inhibitor erlotinib (ERL) electrochemical behavior and interaction with DNA was performed with the aim to clarify its redox mechanism and to determine the mode of binding. Irreversible oxidation and reduction processes of ERL on glassy carbon electrode were investigated using three voltammetric techniques CV, DPV, SWV in pH range between 2.0 and 9.0. Oxidation was established as an adsorption-controlled process, while the reduction manifested diffusion-adsorption mixed controlled process in acidic medium and adsorption became predominant in the neutral solutions. According to the determined number of transferred electrons and protons, oxidation and reduction mechanism of ERL are proposed. To follow the interaction between ERL and DNA, the multilayer ct-DNA electrochemical biosensor was incubated in ERL solutions concentrations ranged from 2 × 10–7 M to 5 × 10–5 M (pH 4.6) for 30 min. SWV measurements have shown the decrease in deoxyadenosine peak current as a consequence of ERL increased concentration and binding to ct-DNA. The calculated value of binding constant was K = 8.25 × 104 M−1. Molecular docking showed that ERL forms hydrophobic interactions when docked into minor groove, as well as when intercalated, and molecular dynamics analysis predicted the stability of obtained complexes. These results together with voltammetric studies imply that the intercalation could be more dominant way ERL binding to DNA compared to minor groove binding.
PB  - Elsevier B.V.
T2  - Journal of Pharmaceutical and Biomedical Analysis
T1  - Electrochemical and theoretical study on interaction between erlotinib and DNA
VL  - 234
DO  - 10.1016/j.jpba.2023.115560
ER  - 
@article{
author = "Jovanović, Milan and Nikolić, Katarina and Čarapić, Marija and Aleksić, Mara",
year = "2023",
abstract = "A comprehensive investigation of tyrosine kinase inhibitor erlotinib (ERL) electrochemical behavior and interaction with DNA was performed with the aim to clarify its redox mechanism and to determine the mode of binding. Irreversible oxidation and reduction processes of ERL on glassy carbon electrode were investigated using three voltammetric techniques CV, DPV, SWV in pH range between 2.0 and 9.0. Oxidation was established as an adsorption-controlled process, while the reduction manifested diffusion-adsorption mixed controlled process in acidic medium and adsorption became predominant in the neutral solutions. According to the determined number of transferred electrons and protons, oxidation and reduction mechanism of ERL are proposed. To follow the interaction between ERL and DNA, the multilayer ct-DNA electrochemical biosensor was incubated in ERL solutions concentrations ranged from 2 × 10–7 M to 5 × 10–5 M (pH 4.6) for 30 min. SWV measurements have shown the decrease in deoxyadenosine peak current as a consequence of ERL increased concentration and binding to ct-DNA. The calculated value of binding constant was K = 8.25 × 104 M−1. Molecular docking showed that ERL forms hydrophobic interactions when docked into minor groove, as well as when intercalated, and molecular dynamics analysis predicted the stability of obtained complexes. These results together with voltammetric studies imply that the intercalation could be more dominant way ERL binding to DNA compared to minor groove binding.",
publisher = "Elsevier B.V.",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
title = "Electrochemical and theoretical study on interaction between erlotinib and DNA",
volume = "234",
doi = "10.1016/j.jpba.2023.115560"
}
Jovanović, M., Nikolić, K., Čarapić, M.,& Aleksić, M.. (2023). Electrochemical and theoretical study on interaction between erlotinib and DNA. in Journal of Pharmaceutical and Biomedical Analysis
Elsevier B.V.., 234.
https://doi.org/10.1016/j.jpba.2023.115560
Jovanović M, Nikolić K, Čarapić M, Aleksić M. Electrochemical and theoretical study on interaction between erlotinib and DNA. in Journal of Pharmaceutical and Biomedical Analysis. 2023;234.
doi:10.1016/j.jpba.2023.115560 .
Jovanović, Milan, Nikolić, Katarina, Čarapić, Marija, Aleksić, Mara, "Electrochemical and theoretical study on interaction between erlotinib and DNA" in Journal of Pharmaceutical and Biomedical Analysis, 234 (2023),
https://doi.org/10.1016/j.jpba.2023.115560 . .
1

QSRR Modeling of liquid chromatography separation of ziprasidone compounds

Čarapić, Marija; Nikolić, Katarina; Agbaba, Danica

(Institute for Information Technologies, University of Kragujevac, Serbia, 2021)

TY  - CONF
AU  - Čarapić, Marija
AU  - Nikolić, Katarina
AU  - Agbaba, Danica
PY  - 2021
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4858
PB  - Institute for Information Technologies, University of Kragujevac, Serbia
C3  - 1st International Conference on Chemo and BioInformatics ICCBIKG 2021 (BOOK OF PROCEEDINGS)
T1  - QSRR Modeling of liquid chromatography separation of ziprasidone compounds
SP  - 284
EP  - 287
DO  - 10.46793/ICCBI21.284C
ER  - 
@conference{
author = "Čarapić, Marija and Nikolić, Katarina and Agbaba, Danica",
year = "2021",
publisher = "Institute for Information Technologies, University of Kragujevac, Serbia",
journal = "1st International Conference on Chemo and BioInformatics ICCBIKG 2021 (BOOK OF PROCEEDINGS)",
title = "QSRR Modeling of liquid chromatography separation of ziprasidone compounds",
pages = "284-287",
doi = "10.46793/ICCBI21.284C"
}
Čarapić, M., Nikolić, K.,& Agbaba, D.. (2021). QSRR Modeling of liquid chromatography separation of ziprasidone compounds. in 1st International Conference on Chemo and BioInformatics ICCBIKG 2021 (BOOK OF PROCEEDINGS)
Institute for Information Technologies, University of Kragujevac, Serbia., 284-287.
https://doi.org/10.46793/ICCBI21.284C
Čarapić M, Nikolić K, Agbaba D. QSRR Modeling of liquid chromatography separation of ziprasidone compounds. in 1st International Conference on Chemo and BioInformatics ICCBIKG 2021 (BOOK OF PROCEEDINGS). 2021;:284-287.
doi:10.46793/ICCBI21.284C .
Čarapić, Marija, Nikolić, Katarina, Agbaba, Danica, "QSRR Modeling of liquid chromatography separation of ziprasidone compounds" in 1st International Conference on Chemo and BioInformatics ICCBIKG 2021 (BOOK OF PROCEEDINGS) (2021):284-287,
https://doi.org/10.46793/ICCBI21.284C . .

Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities

Čarapić, Marija; Nikolić, Katarina; Marković, Bojan; Petković, Miloš; Pavlović, Milena; Agbaba, Danica

(Wiley, Hoboken, 2019)

TY  - JOUR
AU  - Čarapić, Marija
AU  - Nikolić, Katarina
AU  - Marković, Bojan
AU  - Petković, Miloš
AU  - Pavlović, Milena
AU  - Agbaba, Danica
PY  - 2019
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3329
AB  - The separation and characterization of the unknown degradation product of second-generation antipsychotic drug ziprasidone are essential for defining the genotoxic potential of the compound. The aim of this study was to develop a simple UHPLC method coupled with tandem mass spectrometry (MS/MS) for chemical characterization of an unknown degradant, and the separation and quantification of ziprasidone and its five main impurities (I-V) in the raw material and pharmaceuticals. Chromatographic conditions were optimized by experimental design. The MS/MS fragmentation conditions were optimized individually for each compound in order to obtain both specific fragments and high signal intensity. A rapid and sensitive UHPLC-MS/MS method was developed. All seven analytes were eluted within the 7 min run time. The best separation was obtained on the Acquity UPLC BEH C-18 (50 x 2.1 mm x 1.7 mu m) column in gradient mode with ammonium-formate buffer (10 mm; pH 4.7) and acetonitrile as mobile phase, with the flow rate of 0.3 mL min(-1) and at the column temperature of 30 degrees C. The new UHPLC-MS/MS method was fully validated and all validation parameters were confirmed. The fragmentation pathways and chemical characterization of an unknown degradant were proposed and it was confirmed that there are no structural alerts concerning genotoxicity.
PB  - Wiley, Hoboken
T2  - Biomedical Chromatography
T1  - Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities
VL  - 33
IS  - 2
DO  - 10.1002/bmc.4384
ER  - 
@article{
author = "Čarapić, Marija and Nikolić, Katarina and Marković, Bojan and Petković, Miloš and Pavlović, Milena and Agbaba, Danica",
year = "2019",
abstract = "The separation and characterization of the unknown degradation product of second-generation antipsychotic drug ziprasidone are essential for defining the genotoxic potential of the compound. The aim of this study was to develop a simple UHPLC method coupled with tandem mass spectrometry (MS/MS) for chemical characterization of an unknown degradant, and the separation and quantification of ziprasidone and its five main impurities (I-V) in the raw material and pharmaceuticals. Chromatographic conditions were optimized by experimental design. The MS/MS fragmentation conditions were optimized individually for each compound in order to obtain both specific fragments and high signal intensity. A rapid and sensitive UHPLC-MS/MS method was developed. All seven analytes were eluted within the 7 min run time. The best separation was obtained on the Acquity UPLC BEH C-18 (50 x 2.1 mm x 1.7 mu m) column in gradient mode with ammonium-formate buffer (10 mm; pH 4.7) and acetonitrile as mobile phase, with the flow rate of 0.3 mL min(-1) and at the column temperature of 30 degrees C. The new UHPLC-MS/MS method was fully validated and all validation parameters were confirmed. The fragmentation pathways and chemical characterization of an unknown degradant were proposed and it was confirmed that there are no structural alerts concerning genotoxicity.",
publisher = "Wiley, Hoboken",
journal = "Biomedical Chromatography",
title = "Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities",
volume = "33",
number = "2",
doi = "10.1002/bmc.4384"
}
Čarapić, M., Nikolić, K., Marković, B., Petković, M., Pavlović, M.,& Agbaba, D.. (2019). Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities. in Biomedical Chromatography
Wiley, Hoboken., 33(2).
https://doi.org/10.1002/bmc.4384
Čarapić M, Nikolić K, Marković B, Petković M, Pavlović M, Agbaba D. Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities. in Biomedical Chromatography. 2019;33(2).
doi:10.1002/bmc.4384 .
Čarapić, Marija, Nikolić, Katarina, Marković, Bojan, Petković, Miloš, Pavlović, Milena, Agbaba, Danica, "Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities" in Biomedical Chromatography, 33, no. 2 (2019),
https://doi.org/10.1002/bmc.4384 . .
1
3
2

Primena metoda multivarijantnih analiza glavnih komponenti i hijerarhijskog grupisanja u ispitivanju razdvajanja jedinjenja ziprasidona tečnom hromatografijom

Čarapić, Marija; Nikolić, Katarina; Smolinski, Adam; Agbaba, Danica

(Savez farmaceutskih udruženja Srbije (SFUS), 2018)

TY  - CONF
AU  - Čarapić, Marija
AU  - Nikolić, Katarina
AU  - Smolinski, Adam
AU  - Agbaba, Danica
PY  - 2018
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4876
AB  - Ziprasidon je novi atipični antipsihotik druge generacije, koji deluje kao
antagonista na serotoninskim i dopaminskim receptorima, i inhibira preuzimanje
norepinefrina. Glavni cilj hemometrijske studije je ispitivanje selektivnosti 20 reverznofaznih
(RP) stacionarnih faza u odnosu na ziprazidon i šest nečistoća ((I‐V) i
nepoznata). Velika strukturna sličnost ziprasidona i nečistoće II bila je ključni problem i
razdvajanje kritičnog para je bilo odlučujuće za odabir RP stacionarne faze.
Za analizu glavnih komponenti (PCA) korišćen je matematički program Soft
Independent Modeling of Class Analogy SIMCA P+ 12.0, a za analizu hijerarhijskog
grupisanja (HCA) korišćen je program MATLAB ver. 6.5.
Ispitivanje selektivnosti 20 RP stacionarnih faza je vršeno pri dobijenim
optimalnim eksperimentalnim uslovima (25 ºC; pH: 2,5; cTEA: 1% i cKH2PO4: 50mM) u
odnosu na ispitivana jedinjenja. Eksperimentalno dobijeni hromatografski parametri
(broj teoretskih platoa‐N, faktor simetrije pika ‐SF, rezolucija ‐Rs i faktor selektivnosti ‐
α između jedinjenja koja se blizu eluiraju) na 20 RP stacionarnih faza analizirani su
primenom PCA i HCA analiza.
Grafikoni rezultata i PCA koeficijenata variabli za PC1(osnovna komponeta 1) i
PC2 (osnovna komponeta 2) pokazuju glavne razlike između svih 20 RP‐kolona i glavne
sličnosti između hromatografskih parametara. Rs i α su odabrani kao najznačajniji
parametri za izbor stacionarne faze. Dobijeni dendogrami pokazali su tri glavne grupe
za stacionarne faze i četiri grupe za hromatografske parametre. Dendogrami RP kolona
i hromatografskih parametara su prikazani i obojenom mapom što je jednostavnija
metoda vizuelizacije.
Određene su RP stacionarne faze posebno selektivne za efikasno razdvajanje
ziprasidona i strukturno sličnih jedinjenja primenom PCA i HCA (grupa 1 PCA i grupa C
AHC):Waters Spherisorb® ODS1, Waters Spherisorb® ODS2 i Nucleosil® 100‐5 C18.
Dobijeni podaci su u skladu sa eksperimentalnim rezultatima. Odabrana je Waters
Spherisorb® ODS 1 kolona za HPLC metodu u odnosu na najbolju SF i faktor retencije
(k’).
AB  - Ziprasidone is a novel „atypical” or „second generation” antipsychotic drug
which acts primarily through serotonergic and dopaminergic receptor antagonism, and
as an inhibitor of the norepinephrine reuptake. The main aims of the presented
chemometric study was to test selectivity of the set of 20 Reversed‐phase (RP) ‐
columns towards ziprasidone and its six impurities ((I‐V) and one unknown).
Separation of structurally similar pair of ziprasidone/impurity II caused analytical
problems and was decisive for the selection of the suitable RP‐column.
The Principal Component Analysis (PCA) for column classification was done with
use of SIMCA P+ 12.0 program and Hierarchical Clustering Analysis (HCA) with use of
MATLAB ver. 6.5. with additional algorithms.
The obtained optimal chromatographic conditions (25C, pH 2,5, cTEA 1% and
cKH2PO4 50 mM) were used to test a set of 20 RP‐columns. Plate numbers (N),
symmetry factors (SF), resolution (Rs) and selectivity (α) of investigated compounds
were subjected to PCA and HCA analysis. Score plot and loading plots PC1 (principal
component 1) vs PC2 (principal component 2) visualize the main differences between
all 20 RP‐columns and main similarities between hromatographic parameters,
respectively. The Rs and α were selected as the most significant for the column
selection. The obtained dendrograms reveal three distinct clusters of RP‐columns and
four clusters of chromatographic parameters. The color map of data was used as a
simpler presentation of the dendrograms of RP‐columns and chromatographic
parameters.
The RP‐columns selective for the efficient separation of ziprasidone and its
structurally related compounds were defined by PCA and HCA (group 1 in PCA study
and same cluster C in HCA study) : Waters Spherisorb® ODS1, Waters Spherisorb®
ODS2 and Nucleosil® 100‐5 C18. The results were in accordance with experimentally
obtained results. Finally, the column Waters Spherisorb® ODS 1 was selected for the
HPLC method due to best SF and retention factor (k’).
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Primena metoda multivarijantnih analiza glavnih komponenti i hijerarhijskog grupisanja u ispitivanju razdvajanja jedinjenja ziprasidona tečnom hromatografijom
T1  - Modeling of liquid chromatography separation of ziprasidone compounds using multivariate methods of principal component and hierarchical clustering analysis
VL  - 68
IS  - 3
SP  - 411
EP  - 412
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4876
ER  - 
@conference{
author = "Čarapić, Marija and Nikolić, Katarina and Smolinski, Adam and Agbaba, Danica",
year = "2018",
abstract = "Ziprasidon je novi atipični antipsihotik druge generacije, koji deluje kao
antagonista na serotoninskim i dopaminskim receptorima, i inhibira preuzimanje
norepinefrina. Glavni cilj hemometrijske studije je ispitivanje selektivnosti 20 reverznofaznih
(RP) stacionarnih faza u odnosu na ziprazidon i šest nečistoća ((I‐V) i
nepoznata). Velika strukturna sličnost ziprasidona i nečistoće II bila je ključni problem i
razdvajanje kritičnog para je bilo odlučujuće za odabir RP stacionarne faze.
Za analizu glavnih komponenti (PCA) korišćen je matematički program Soft
Independent Modeling of Class Analogy SIMCA P+ 12.0, a za analizu hijerarhijskog
grupisanja (HCA) korišćen je program MATLAB ver. 6.5.
Ispitivanje selektivnosti 20 RP stacionarnih faza je vršeno pri dobijenim
optimalnim eksperimentalnim uslovima (25 ºC; pH: 2,5; cTEA: 1% i cKH2PO4: 50mM) u
odnosu na ispitivana jedinjenja. Eksperimentalno dobijeni hromatografski parametri
(broj teoretskih platoa‐N, faktor simetrije pika ‐SF, rezolucija ‐Rs i faktor selektivnosti ‐
α između jedinjenja koja se blizu eluiraju) na 20 RP stacionarnih faza analizirani su
primenom PCA i HCA analiza.
Grafikoni rezultata i PCA koeficijenata variabli za PC1(osnovna komponeta 1) i
PC2 (osnovna komponeta 2) pokazuju glavne razlike između svih 20 RP‐kolona i glavne
sličnosti između hromatografskih parametara. Rs i α su odabrani kao najznačajniji
parametri za izbor stacionarne faze. Dobijeni dendogrami pokazali su tri glavne grupe
za stacionarne faze i četiri grupe za hromatografske parametre. Dendogrami RP kolona
i hromatografskih parametara su prikazani i obojenom mapom što je jednostavnija
metoda vizuelizacije.
Određene su RP stacionarne faze posebno selektivne za efikasno razdvajanje
ziprasidona i strukturno sličnih jedinjenja primenom PCA i HCA (grupa 1 PCA i grupa C
AHC):Waters Spherisorb® ODS1, Waters Spherisorb® ODS2 i Nucleosil® 100‐5 C18.
Dobijeni podaci su u skladu sa eksperimentalnim rezultatima. Odabrana je Waters
Spherisorb® ODS 1 kolona za HPLC metodu u odnosu na najbolju SF i faktor retencije
(k’)., Ziprasidone is a novel „atypical” or „second generation” antipsychotic drug
which acts primarily through serotonergic and dopaminergic receptor antagonism, and
as an inhibitor of the norepinephrine reuptake. The main aims of the presented
chemometric study was to test selectivity of the set of 20 Reversed‐phase (RP) ‐
columns towards ziprasidone and its six impurities ((I‐V) and one unknown).
Separation of structurally similar pair of ziprasidone/impurity II caused analytical
problems and was decisive for the selection of the suitable RP‐column.
The Principal Component Analysis (PCA) for column classification was done with
use of SIMCA P+ 12.0 program and Hierarchical Clustering Analysis (HCA) with use of
MATLAB ver. 6.5. with additional algorithms.
The obtained optimal chromatographic conditions (25C, pH 2,5, cTEA 1% and
cKH2PO4 50 mM) were used to test a set of 20 RP‐columns. Plate numbers (N),
symmetry factors (SF), resolution (Rs) and selectivity (α) of investigated compounds
were subjected to PCA and HCA analysis. Score plot and loading plots PC1 (principal
component 1) vs PC2 (principal component 2) visualize the main differences between
all 20 RP‐columns and main similarities between hromatographic parameters,
respectively. The Rs and α were selected as the most significant for the column
selection. The obtained dendrograms reveal three distinct clusters of RP‐columns and
four clusters of chromatographic parameters. The color map of data was used as a
simpler presentation of the dendrograms of RP‐columns and chromatographic
parameters.
The RP‐columns selective for the efficient separation of ziprasidone and its
structurally related compounds were defined by PCA and HCA (group 1 in PCA study
and same cluster C in HCA study) : Waters Spherisorb® ODS1, Waters Spherisorb®
ODS2 and Nucleosil® 100‐5 C18. The results were in accordance with experimentally
obtained results. Finally, the column Waters Spherisorb® ODS 1 was selected for the
HPLC method due to best SF and retention factor (k’).",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Primena metoda multivarijantnih analiza glavnih komponenti i hijerarhijskog grupisanja u ispitivanju razdvajanja jedinjenja ziprasidona tečnom hromatografijom, Modeling of liquid chromatography separation of ziprasidone compounds using multivariate methods of principal component and hierarchical clustering analysis",
volume = "68",
number = "3",
pages = "411-412",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4876"
}
Čarapić, M., Nikolić, K., Smolinski, A.,& Agbaba, D.. (2018). Primena metoda multivarijantnih analiza glavnih komponenti i hijerarhijskog grupisanja u ispitivanju razdvajanja jedinjenja ziprasidona tečnom hromatografijom. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 68(3), 411-412.
https://hdl.handle.net/21.15107/rcub_farfar_4876
Čarapić M, Nikolić K, Smolinski A, Agbaba D. Primena metoda multivarijantnih analiza glavnih komponenti i hijerarhijskog grupisanja u ispitivanju razdvajanja jedinjenja ziprasidona tečnom hromatografijom. in Arhiv za farmaciju. 2018;68(3):411-412.
https://hdl.handle.net/21.15107/rcub_farfar_4876 .
Čarapić, Marija, Nikolić, Katarina, Smolinski, Adam, Agbaba, Danica, "Primena metoda multivarijantnih analiza glavnih komponenti i hijerarhijskog grupisanja u ispitivanju razdvajanja jedinjenja ziprasidona tečnom hromatografijom" in Arhiv za farmaciju, 68, no. 3 (2018):411-412,
https://hdl.handle.net/21.15107/rcub_farfar_4876 .

Possibilities of instrumental planar chromatography in drug analysis

Oljačić, Slavica; Nikolić, Katarina; Čarapić, Marija; Obradović, Darija; Agbaba, Danica

(Institute of Chemistry University of Silesia in Katowice, 2017)

TY  - CONF
AU  - Oljačić, Slavica
AU  - Nikolić, Katarina
AU  - Čarapić, Marija
AU  - Obradović, Darija
AU  - Agbaba, Danica
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5154
AB  - Demands to ensure safe and secure medicinal products for protection and treatment of
human health and society led to the development and implementation of numerous high
performance instrumental techniques for the estimation of their quality. ...
PB  - Institute of Chemistry University of Silesia in Katowice
C3  - 40th Symposium Chromatographic methods of investigating the organic compounds: Book of Abstracts
T1  - Possibilities of instrumental planar chromatography in drug analysis
SP  - 1
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5154
ER  - 
@conference{
author = "Oljačić, Slavica and Nikolić, Katarina and Čarapić, Marija and Obradović, Darija and Agbaba, Danica",
year = "2017",
abstract = "Demands to ensure safe and secure medicinal products for protection and treatment of
human health and society led to the development and implementation of numerous high
performance instrumental techniques for the estimation of their quality. ...",
publisher = "Institute of Chemistry University of Silesia in Katowice",
journal = "40th Symposium Chromatographic methods of investigating the organic compounds: Book of Abstracts",
title = "Possibilities of instrumental planar chromatography in drug analysis",
pages = "1",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5154"
}
Oljačić, S., Nikolić, K., Čarapić, M., Obradović, D.,& Agbaba, D.. (2017). Possibilities of instrumental planar chromatography in drug analysis. in 40th Symposium Chromatographic methods of investigating the organic compounds: Book of Abstracts
Institute of Chemistry University of Silesia in Katowice., 1.
https://hdl.handle.net/21.15107/rcub_farfar_5154
Oljačić S, Nikolić K, Čarapić M, Obradović D, Agbaba D. Possibilities of instrumental planar chromatography in drug analysis. in 40th Symposium Chromatographic methods of investigating the organic compounds: Book of Abstracts. 2017;:1.
https://hdl.handle.net/21.15107/rcub_farfar_5154 .
Oljačić, Slavica, Nikolić, Katarina, Čarapić, Marija, Obradović, Darija, Agbaba, Danica, "Possibilities of instrumental planar chromatography in drug analysis" in 40th Symposium Chromatographic methods of investigating the organic compounds: Book of Abstracts (2017):1,
https://hdl.handle.net/21.15107/rcub_farfar_5154 .

Optimization of TLC method for separation and determination of ziprasidone and its impurities

Obradović, Darija; Filipić, Slavica; Nikolić, Katarina; Carapić, Marija; Agbaba, Danica

(Taylor & Francis Inc, Philadelphia, 2016)

TY  - JOUR
AU  - Obradović, Darija
AU  - Filipić, Slavica
AU  - Nikolić, Katarina
AU  - Carapić, Marija
AU  - Agbaba, Danica
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3433
AB  - A thin-layer chromatographic method for simultaneous determination of ziprasidone and its main impurities was developed and validated. Separation of the examined compounds was performed on chromatographic plates precoated with silica gel 60 F-254 and using toluene-methanol-glacial acetic acid, 7.5:0.5:0.5 (v/v/v) as mobile phase. Ascending development mode was performed in the twin-trough chromatographic chamber, which was presaturated with mobile-phase vapors for 15 min. The developed chromatographic plates were dried in air and densitometrically scanned at the wavelengths of 250 and 320 nm. Regression coefficient (r >= 0.992), recovery (94.94-106.70%), limit of quantification of impurities (25 ng band(-1) equivalent to the 0.14% impurity level), and robustness were validated and found satisfactory. The developed method is convenient for quantitative analysis and the purity screening of ziprasidone in pharmaceutical formulations.
PB  - Taylor & Francis Inc, Philadelphia
T2  - Journal of Liquid Chromatography & Related Technologies
T1  - Optimization of TLC method for separation and determination of ziprasidone and its impurities
VL  - 39
IS  - 5-6
SP  - 271
EP  - 276
DO  - 10.1080/10826076.2016.1163183
ER  - 
@article{
author = "Obradović, Darija and Filipić, Slavica and Nikolić, Katarina and Carapić, Marija and Agbaba, Danica",
year = "2016",
abstract = "A thin-layer chromatographic method for simultaneous determination of ziprasidone and its main impurities was developed and validated. Separation of the examined compounds was performed on chromatographic plates precoated with silica gel 60 F-254 and using toluene-methanol-glacial acetic acid, 7.5:0.5:0.5 (v/v/v) as mobile phase. Ascending development mode was performed in the twin-trough chromatographic chamber, which was presaturated with mobile-phase vapors for 15 min. The developed chromatographic plates were dried in air and densitometrically scanned at the wavelengths of 250 and 320 nm. Regression coefficient (r >= 0.992), recovery (94.94-106.70%), limit of quantification of impurities (25 ng band(-1) equivalent to the 0.14% impurity level), and robustness were validated and found satisfactory. The developed method is convenient for quantitative analysis and the purity screening of ziprasidone in pharmaceutical formulations.",
publisher = "Taylor & Francis Inc, Philadelphia",
journal = "Journal of Liquid Chromatography & Related Technologies",
title = "Optimization of TLC method for separation and determination of ziprasidone and its impurities",
volume = "39",
number = "5-6",
pages = "271-276",
doi = "10.1080/10826076.2016.1163183"
}
Obradović, D., Filipić, S., Nikolić, K., Carapić, M.,& Agbaba, D.. (2016). Optimization of TLC method for separation and determination of ziprasidone and its impurities. in Journal of Liquid Chromatography & Related Technologies
Taylor & Francis Inc, Philadelphia., 39(5-6), 271-276.
https://doi.org/10.1080/10826076.2016.1163183
Obradović D, Filipić S, Nikolić K, Carapić M, Agbaba D. Optimization of TLC method for separation and determination of ziprasidone and its impurities. in Journal of Liquid Chromatography & Related Technologies. 2016;39(5-6):271-276.
doi:10.1080/10826076.2016.1163183 .
Obradović, Darija, Filipić, Slavica, Nikolić, Katarina, Carapić, Marija, Agbaba, Danica, "Optimization of TLC method for separation and determination of ziprasidone and its impurities" in Journal of Liquid Chromatography & Related Technologies, 39, no. 5-6 (2016):271-276,
https://doi.org/10.1080/10826076.2016.1163183 . .
9
5
8

Optimization of TLC method for separation and determination of ziprasidone and its impurities

Obradović, Darija; Filipić, Slavica; Nikolić, Katarina; Carapić, Marija; Agbaba, Danica

(Taylor & Francis Inc, Philadelphia, 2016)

TY  - JOUR
AU  - Obradović, Darija
AU  - Filipić, Slavica
AU  - Nikolić, Katarina
AU  - Carapić, Marija
AU  - Agbaba, Danica
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2535
AB  - A thin-layer chromatographic method for simultaneous determination of ziprasidone and its main impurities was developed and validated. Separation of the examined compounds was performed on chromatographic plates precoated with silica gel 60 F-254 and using toluene-methanol-glacial acetic acid, 7.5:0.5:0.5 (v/v/v) as mobile phase. Ascending development mode was performed in the twin-trough chromatographic chamber, which was presaturated with mobile-phase vapors for 15 min. The developed chromatographic plates were dried in air and densitometrically scanned at the wavelengths of 250 and 320 nm. Regression coefficient (r >= 0.992), recovery (94.94-106.70%), limit of quantification of impurities (25 ng band(-1) equivalent to the 0.14% impurity level), and robustness were validated and found satisfactory. The developed method is convenient for quantitative analysis and the purity screening of ziprasidone in pharmaceutical formulations.
PB  - Taylor & Francis Inc, Philadelphia
T2  - Journal of Liquid Chromatography & Related Technologies
T1  - Optimization of TLC method for separation and determination of ziprasidone and its impurities
VL  - 39
IS  - 5-6
SP  - 271
EP  - 276
DO  - 10.1080/10826076.2016.1163183
ER  - 
@article{
author = "Obradović, Darija and Filipić, Slavica and Nikolić, Katarina and Carapić, Marija and Agbaba, Danica",
year = "2016",
abstract = "A thin-layer chromatographic method for simultaneous determination of ziprasidone and its main impurities was developed and validated. Separation of the examined compounds was performed on chromatographic plates precoated with silica gel 60 F-254 and using toluene-methanol-glacial acetic acid, 7.5:0.5:0.5 (v/v/v) as mobile phase. Ascending development mode was performed in the twin-trough chromatographic chamber, which was presaturated with mobile-phase vapors for 15 min. The developed chromatographic plates were dried in air and densitometrically scanned at the wavelengths of 250 and 320 nm. Regression coefficient (r >= 0.992), recovery (94.94-106.70%), limit of quantification of impurities (25 ng band(-1) equivalent to the 0.14% impurity level), and robustness were validated and found satisfactory. The developed method is convenient for quantitative analysis and the purity screening of ziprasidone in pharmaceutical formulations.",
publisher = "Taylor & Francis Inc, Philadelphia",
journal = "Journal of Liquid Chromatography & Related Technologies",
title = "Optimization of TLC method for separation and determination of ziprasidone and its impurities",
volume = "39",
number = "5-6",
pages = "271-276",
doi = "10.1080/10826076.2016.1163183"
}
Obradović, D., Filipić, S., Nikolić, K., Carapić, M.,& Agbaba, D.. (2016). Optimization of TLC method for separation and determination of ziprasidone and its impurities. in Journal of Liquid Chromatography & Related Technologies
Taylor & Francis Inc, Philadelphia., 39(5-6), 271-276.
https://doi.org/10.1080/10826076.2016.1163183
Obradović D, Filipić S, Nikolić K, Carapić M, Agbaba D. Optimization of TLC method for separation and determination of ziprasidone and its impurities. in Journal of Liquid Chromatography & Related Technologies. 2016;39(5-6):271-276.
doi:10.1080/10826076.2016.1163183 .
Obradović, Darija, Filipić, Slavica, Nikolić, Katarina, Carapić, Marija, Agbaba, Danica, "Optimization of TLC method for separation and determination of ziprasidone and its impurities" in Journal of Liquid Chromatography & Related Technologies, 39, no. 5-6 (2016):271-276,
https://doi.org/10.1080/10826076.2016.1163183 . .
9
5
8